Login to Your Account



'Jittery' Wall Street Drops Palatin: ED Drug Positive In Phase II Trial

By Randall Osborne


Tuesday, November 4, 2003
Palatin Technologies Inc. reported positive data from a Phase IIb trial with PT-141, an erectile dysfunction drug that has not only proved effective but also - thanks to a different mechanism of action - gets around the potential cardiovascular problems with existing therapies. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription